Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma
2003; Massachusetts Medical Society; Volume: 348; Issue: 24 Linguagem: Inglês
10.1056/nejmoa022628
ISSN1533-4406
AutoresBerthe M.P. Aleman, John Raemaekers, Umberto Tirelli, Roberto Bortolus, Mars B. van ’t Veer, Marnix L.M. Lybeert, Jo J. Keuning, Patrice Carde, T. Girinsky, Richard W.M. van der Maazen, Radka Tomšič, Marjeta Vovk, Achilles Van Hoof, Geertrui Demeestere, Pieternella J. Lugtenburg, José Thomas, Wilfried Schroyens, Koenraad De Boeck, Johanna W. Baars, Hanneke C. Kluin‐Nelemans, C. Carrié, Malek Aoudjhane, Dominique Bron, Houchingue Eghbali, Wilma G.J.M. Smit, J.H. Meerwaldt, Anton Hagenbeek, A. Pinna, M. Henry‐Amar,
Tópico(s)CNS Lymphoma Diagnosis and Treatment
ResumoThe use of involved-field radiotherapy after chemotherapy for advanced Hodgkin's lymphoma is controversial.
Referência(s)